NVCR Insider Trading Activity and SEC Form 4 Filings
NVCR insider trading summary
Over the past 12 months, insiders at NovoCure Ltd (NVCR) reported 20 sales worth $2.4M by 14 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.4M.
Latest NVCR insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 2, 2026 | Michal Nath Puri | Chief Human Resources Officer | Sell | $9K (660 @ $13.24) |
| Jun 2, 2026 | Jeryl L Hilleman | Insider | Sell | $46K (2,945 @ $15.77) |
| Jun 2, 2026 | Timothy J Scannell | Insider | Sell | $46K (2,945 @ $15.77) |
| Jun 2, 2026 | Allyson J Ocean | Insider | Sell | $46K (2,945 @ $15.77) |
| Jun 2, 2026 | Kristin Stafford | Insider | Sell | $46K (2,945 @ $15.77) |
| Jun 2, 2026 | Gabriel Leung | Insider | Sell | $46K (2,945 @ $15.77) |
| Jun 2, 2026 | W Anthony Vernon | Insider | Sell | $46K (2,945 @ $15.77) |
| Jun 2, 2026 | David Hung | Insider | Sell | $46K (2,945 @ $15.77) |
| Mar 5, 2026 | Mukund Paravasthu | Chief Operating Officer | Sell | $596K (43,246 @ $13.77) |
| Mar 4, 2026 | Mukund Paravasthu | Chief Operating Officer | Sell | $72K (5,377 @ $13.31) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.